Showing results (31-40 of 137) with videos related to
Sort By:
Pageof 14
British Journal of Cancer|March 25, 2000
Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genesN Soufir, B Bressac-de Paillerets, L Desjardins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1983
Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomitingN Colbert, V Izrael, J P Lotz, et al.Disease Markers|December 14, 1999
Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le CancerH Sobol, Y J Bignon, C Bonaiti, et al.Familial Cancer|October 24, 2003
Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveysF Eisinger, D Stoppa-Lyonnet, C Lasset, et al.Bulletin Du Cancer|October 1, 1993
[Hereditary predisposition for cancer of the breast and the ovary]P Lalle, D Stoppa-Lyonnet, S Mazoyer, et al.Cancer Research|February 1, 1996
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancerF Eisinger, D Stoppa-Lyonnet, M Longy, et al.Human Molecular Genetics|March 21, 1998
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study GroupN Soufir, M F Avril, A Chompret, et al.Disease Markers|December 14, 1999
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast CancerJ Chang-Claude, H Becher, M Caligo, et al.British Journal of Cancer|October 25, 2000
Low expression of bcl-2 in Brca1-associated breast cancersP Freneaux, D Stoppa-Lyonnet, E Mouret, et al.Genomics|January 25, 2000
Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutationsT Wagner, D Stoppa-Lyonnet, E Fleischmann, et al.Pageof 14